CA2729656A1 - Imidazopyrimidinones and uses thereof - Google Patents
Imidazopyrimidinones and uses thereof Download PDFInfo
- Publication number
- CA2729656A1 CA2729656A1 CA2729656A CA2729656A CA2729656A1 CA 2729656 A1 CA2729656 A1 CA 2729656A1 CA 2729656 A CA2729656 A CA 2729656A CA 2729656 A CA2729656 A CA 2729656A CA 2729656 A1 CA2729656 A1 CA 2729656A1
- Authority
- CA
- Canada
- Prior art keywords
- oxo
- group
- product
- 3alkylene
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- BOUNFBOFBGBYBT-UHFFFAOYSA-N purin-8-one Chemical class C1=NC=NC2=NC(=O)N=C21 BOUNFBOFBGBYBT-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 154
- 150000001875 compounds Chemical class 0.000 claims abstract description 115
- 150000003839 salts Chemical class 0.000 claims abstract description 24
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 239000000651 prodrug Substances 0.000 claims abstract description 19
- 229940002612 prodrug Drugs 0.000 claims abstract description 19
- 208000036142 Viral infection Diseases 0.000 claims abstract description 13
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 13
- 230000009385 viral infection Effects 0.000 claims abstract description 13
- 238000011321 prophylaxis Methods 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims description 183
- 229910052739 hydrogen Inorganic materials 0.000 claims description 51
- -1 C1-10alkylNR3R4 Chemical group 0.000 claims description 50
- 125000001424 substituent group Chemical group 0.000 claims description 35
- 125000004432 carbon atom Chemical group C* 0.000 claims description 33
- 229910052717 sulfur Inorganic materials 0.000 claims description 33
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 32
- 125000005843 halogen group Chemical group 0.000 claims description 29
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 24
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 24
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 22
- 229910052757 nitrogen Inorganic materials 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 21
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 21
- 125000005842 heteroatom Chemical group 0.000 claims description 20
- 239000001257 hydrogen Substances 0.000 claims description 20
- 230000035772 mutation Effects 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 17
- 125000000623 heterocyclic group Chemical group 0.000 claims description 16
- 230000003612 virological effect Effects 0.000 claims description 16
- 229910052799 carbon Inorganic materials 0.000 claims description 14
- 229920006395 saturated elastomer Polymers 0.000 claims description 14
- 208000015181 infectious disease Diseases 0.000 claims description 13
- 230000003647 oxidation Effects 0.000 claims description 13
- 238000007254 oxidation reaction Methods 0.000 claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 10
- 125000001072 heteroaryl group Chemical group 0.000 claims description 10
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 108010002459 HIV Integrase Proteins 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 229940124524 integrase inhibitor Drugs 0.000 claims description 8
- 239000002850 integrase inhibitor Substances 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 8
- 239000003085 diluting agent Substances 0.000 claims description 7
- 229940124530 sulfonamide Drugs 0.000 claims description 7
- 125000004122 cyclic group Chemical group 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 102220076678 rs146651027 Human genes 0.000 claims description 6
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims description 6
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 5
- 125000006713 (C5-C10) cycloalkyl group Chemical group 0.000 claims description 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 4
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical group C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000005213 alkyl heteroaryl group Chemical group 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 150000003951 lactams Chemical class 0.000 claims description 3
- CZSRXHJVZUBEGW-UHFFFAOYSA-N 1,2-thiazolidine Chemical compound C1CNSC1 CZSRXHJVZUBEGW-UHFFFAOYSA-N 0.000 claims description 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 229960003586 elvitegravir Drugs 0.000 claims description 2
- JUZYLCPPVHEVSV-LJQANCHMSA-N elvitegravir Chemical compound COC1=CC=2N([C@H](CO)C(C)C)C=C(C(O)=O)C(=O)C=2C=C1CC1=CC=CC(Cl)=C1F JUZYLCPPVHEVSV-LJQANCHMSA-N 0.000 claims description 2
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims description 2
- 150000003536 tetrazoles Chemical group 0.000 claims description 2
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical group C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims description 2
- 150000003852 triazoles Chemical group 0.000 claims description 2
- 239000000047 product Substances 0.000 description 213
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 208
- 238000005481 NMR spectroscopy Methods 0.000 description 151
- 239000000203 mixture Substances 0.000 description 105
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 103
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 70
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 67
- 239000000243 solution Substances 0.000 description 54
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- 229910001868 water Inorganic materials 0.000 description 43
- 101150041968 CDC13 gene Proteins 0.000 description 40
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- 239000007787 solid Substances 0.000 description 30
- 238000004440 column chromatography Methods 0.000 description 29
- 238000010511 deprotection reaction Methods 0.000 description 27
- 229910052740 iodine Inorganic materials 0.000 description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 23
- 235000019439 ethyl acetate Nutrition 0.000 description 23
- 241000700605 Viruses Species 0.000 description 22
- 239000012267 brine Substances 0.000 description 22
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 21
- 102100034343 Integrase Human genes 0.000 description 21
- 108010061833 Integrases Proteins 0.000 description 21
- 229940093499 ethyl acetate Drugs 0.000 description 21
- 230000002829 reductive effect Effects 0.000 description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 20
- 238000003556 assay Methods 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 241000725303 Human immunodeficiency virus Species 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- 238000004128 high performance liquid chromatography Methods 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 15
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 15
- 239000002253 acid Substances 0.000 description 15
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 15
- 229910052938 sodium sulfate Inorganic materials 0.000 description 15
- 235000011152 sodium sulphate Nutrition 0.000 description 15
- 238000001212 derivatisation Methods 0.000 description 14
- 238000005160 1H NMR spectroscopy Methods 0.000 description 13
- SLUYEZHWAHGANQ-UHFFFAOYSA-N 3h-imidazo[1,2-a]pyrimidin-5-one Chemical compound O=C1C=CN=C2N=CCN12 SLUYEZHWAHGANQ-UHFFFAOYSA-N 0.000 description 13
- 239000000284 extract Substances 0.000 description 13
- 239000012044 organic layer Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 230000008878 coupling Effects 0.000 description 11
- 238000010168 coupling process Methods 0.000 description 11
- 238000005859 coupling reaction Methods 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- CZFFBEXEKNGXKS-UHFFFAOYSA-N raltegravir Chemical compound O1C(C)=NN=C1C(=O)NC(C)(C)C1=NC(C(=O)NCC=2C=CC(F)=CC=2)=C(O)C(=O)N1C CZFFBEXEKNGXKS-UHFFFAOYSA-N 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 239000012043 crude product Substances 0.000 description 9
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- UHDHWOXRBRJTDM-UHFFFAOYSA-N 2-(aminomethyl)-5-fluoro-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC(F)=CC=C1CN UHDHWOXRBRJTDM-UHFFFAOYSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- 230000001404 mediated effect Effects 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- 229960004742 raltegravir Drugs 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- 239000000460 chlorine Substances 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- BDTRIDKONHOQQN-UHFFFAOYSA-N 4h-pyrimidin-5-one Chemical compound O=C1CN=CN=C1 BDTRIDKONHOQQN-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000007822 coupling agent Substances 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 229910052731 fluorine Inorganic materials 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 235000015320 potassium carbonate Nutrition 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- IXHNFOOSLAWRBQ-UHFFFAOYSA-N (3,4-dichlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C(Cl)=C1 IXHNFOOSLAWRBQ-UHFFFAOYSA-N 0.000 description 5
- BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 208000031886 HIV Infections Diseases 0.000 description 5
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 5
- 239000007832 Na2SO4 Substances 0.000 description 5
- 230000010933 acylation Effects 0.000 description 5
- 238000005917 acylation reaction Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 230000001566 pro-viral effect Effects 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 239000013605 shuttle vector Substances 0.000 description 5
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- 108060001084 Luciferase Proteins 0.000 description 4
- 239000005089 Luciferase Substances 0.000 description 4
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 229960004132 diethyl ether Drugs 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- UONGQILKBBDHDJ-UHFFFAOYSA-N n,n',n'-trimethyloxamide Chemical compound CNC(=O)C(=O)N(C)C UONGQILKBBDHDJ-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 230000035892 strand transfer Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 3
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- UUHMFGQYTIQQIS-UHFFFAOYSA-N 1h-imidazo[1,2-a]pyrimidin-5-one Chemical compound O=C1C=CN=C2NC=CN12 UUHMFGQYTIQQIS-UHFFFAOYSA-N 0.000 description 3
- YHPVIBUEXBEHPV-UHFFFAOYSA-N 2,6-dihydro-1h-pyrimidin-5-one Chemical compound O=C1CNCN=C1 YHPVIBUEXBEHPV-UHFFFAOYSA-N 0.000 description 3
- LULAYUGMBFYYEX-UHFFFAOYSA-N 3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 3
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 3
- 208000037357 HIV infectious disease Diseases 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000029936 alkylation Effects 0.000 description 3
- 238000005804 alkylation reaction Methods 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012024 dehydrating agents Substances 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- WLRVQBMWJDBJTI-UHFFFAOYSA-N methyl 1-[2-(3,5-dimethylpiperidin-1-yl)-2-oxoethyl]-6-hydroxy-3-(methylsulfanylmethyl)-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=C(CSC)N2C(=O)C(O)=C(C(=O)OC)N=C2N1CC(=O)N1CC(C)CC(C)C1 WLRVQBMWJDBJTI-UHFFFAOYSA-N 0.000 description 3
- LUCZHWHTIYRJIT-UHFFFAOYSA-N methyl 3-(4-fluoro-2-methylsulfanylphenyl)propanoate Chemical compound COC(=O)CCC1=CC=C(F)C=C1SC LUCZHWHTIYRJIT-UHFFFAOYSA-N 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 238000007144 microwave assisted synthesis reaction Methods 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000002741 site-directed mutagenesis Methods 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KDDNKZCVYQDGKE-UHFFFAOYSA-N (2-chlorophenyl)methanamine Chemical compound NCC1=CC=CC=C1Cl KDDNKZCVYQDGKE-UHFFFAOYSA-N 0.000 description 2
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 2
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 2
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 2
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-bis(diphenylphosphino)propane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 2
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NNWUEBIEOFQMSS-UHFFFAOYSA-N 2-Methylpiperidine Chemical compound CC1CCCCN1 NNWUEBIEOFQMSS-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 2
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 2
- YGCZTXZTJXYWCO-UHFFFAOYSA-N 3-phenylpropanal Chemical compound O=CCCC1=CC=CC=C1 YGCZTXZTJXYWCO-UHFFFAOYSA-N 0.000 description 2
- SUMMGYWOUYPCLG-UHFFFAOYSA-N 4-(5-fluoro-2-methoxyphenyl)sulfonylmorpholine Chemical compound COC1=CC=C(F)C=C1S(=O)(=O)N1CCOCC1 SUMMGYWOUYPCLG-UHFFFAOYSA-N 0.000 description 2
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 2
- LRDIEHDJWYRVPT-UHFFFAOYSA-N 4-amino-5-hydroxynaphthalene-1-sulfonic acid Chemical compound C1=CC(O)=C2C(N)=CC=C(S(O)(=O)=O)C2=C1 LRDIEHDJWYRVPT-UHFFFAOYSA-N 0.000 description 2
- FRLHKYPSIFNNRO-UHFFFAOYSA-N 4-fluoro-1-iodo-2-methylsulfanylbenzene Chemical compound CSC1=CC(F)=CC=C1I FRLHKYPSIFNNRO-UHFFFAOYSA-N 0.000 description 2
- YRTOKUYTGQNTNG-UHFFFAOYSA-N 4-fluoro-2-methylsulfanyl-1-nitrobenzene Chemical compound CSC1=CC(F)=CC=C1[N+]([O-])=O YRTOKUYTGQNTNG-UHFFFAOYSA-N 0.000 description 2
- XHSYLYGERVHSMT-UHFFFAOYSA-N 4-fluoro-2-morpholin-4-ylsulfonylphenol Chemical compound OC1=CC=C(F)C=C1S(=O)(=O)N1CCOCC1 XHSYLYGERVHSMT-UHFFFAOYSA-N 0.000 description 2
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical class OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 102000012330 Integrases Human genes 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 101100412859 Mus musculus Rhof gene Proteins 0.000 description 2
- 229910017912 NH2OH Inorganic materials 0.000 description 2
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 241000254064 Photinus pyralis Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000711975 Vesicular stomatitis virus Species 0.000 description 2
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- XXTZHYXQVWRADW-UHFFFAOYSA-N diazomethanone Chemical compound [N]N=C=O XXTZHYXQVWRADW-UHFFFAOYSA-N 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229940111682 isentress Drugs 0.000 description 2
- NJSGAMILODSGLG-UHFFFAOYSA-N methyl 3-(4-fluoro-2-methylsulfanylphenyl)prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(F)C=C1SC NJSGAMILODSGLG-UHFFFAOYSA-N 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N methylsulphonylmethane Natural products CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical class O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 2
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- NZXXKALXHWDVFO-UHFFFAOYSA-N (4-fluoro-2-morpholin-4-ylsulfonylphenyl) trifluoromethanesulfonate Chemical compound FC1=CC=C(OS(=O)(=O)C(F)(F)F)C(S(=O)(=O)N2CCOCC2)=C1 NZXXKALXHWDVFO-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- NADPFZNWCQIJJW-UHFFFAOYSA-N 1,2-dichloro-4-iodobenzene Chemical compound ClC1=CC=C(I)C=C1Cl NADPFZNWCQIJJW-UHFFFAOYSA-N 0.000 description 1
- YYUIROVDIXDEKU-UHFFFAOYSA-N 1,3,4-oxathiazole Chemical compound C1OC=NS1 YYUIROVDIXDEKU-UHFFFAOYSA-N 0.000 description 1
- MBIZXFATKUQOOA-UHFFFAOYSA-N 1,3,4-thiadiazole Chemical compound C1=NN=CS1 MBIZXFATKUQOOA-UHFFFAOYSA-N 0.000 description 1
- OXCGBSWAHMEPTR-UHFFFAOYSA-N 1-(2,6-dimethylmorpholin-4-yl)-2-iodoethanone Chemical compound CC1CN(C(=O)CI)CC(C)O1 OXCGBSWAHMEPTR-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- CJMUVZGTFCOILO-UHFFFAOYSA-N 1-[1-(2,6-dimethylmorpholin-4-yl)-1-oxopropan-2-yl]-7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-6-hydroxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1=CN(C(C(O)=C(C=2SC(CC=3C=CC(F)=CC=3)=CN=2)N=2)=O)C=2N1C(C)C(=O)N1CC(C)OC(C)C1 CJMUVZGTFCOILO-UHFFFAOYSA-N 0.000 description 1
- JEYRKGUIDKDARE-UHFFFAOYSA-N 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C(O)=O)=C2OCC1=CC=CC=C1 JEYRKGUIDKDARE-UHFFFAOYSA-N 0.000 description 1
- QFUBASUZPOEFRG-UHFFFAOYSA-N 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-7-[5-[(4-fluoro-2-methylsulfanylphenyl)methyl]-1,3-thiazol-2-yl]-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound CSC1=CC(F)=CC=C1CC1=CN=C(C2=C(C(=O)N3C=CN(CC(=O)N4CC(C)OC(C)C4)C3=N2)OCC=2C=CC=CC=2)S1 QFUBASUZPOEFRG-UHFFFAOYSA-N 0.000 description 1
- HFZKETCCOQMKCX-UHFFFAOYSA-N 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-7-[5-[(4-fluoro-2-methylsulfinylphenyl)methyl]-1,3-thiazol-2-yl]-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C(=CC(F)=CC=3)S(C)=O)=CN=1)=C2OCC1=CC=CC=C1 HFZKETCCOQMKCX-UHFFFAOYSA-N 0.000 description 1
- AQBXYIQQHRWGLD-UHFFFAOYSA-N 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-7-[5-[(4-fluoro-2-methylsulfonylphenyl)methyl]-1,3-thiazol-2-yl]-6-hydroxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN1C2=NC(C=3SC(CC=4C(=CC(F)=CC=4)S(C)(=O)=O)=CN=3)=C(O)C(=O)N2C=C1 AQBXYIQQHRWGLD-UHFFFAOYSA-N 0.000 description 1
- OBGLQIZVGSZFOB-UHFFFAOYSA-N 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-7-[5-[(4-fluoro-2-methylsulfonylphenyl)methyl]-1,3-thiazol-2-yl]-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C(=CC(F)=CC=3)S(C)(=O)=O)=CN=1)=C2OCC1=CC=CC=C1 OBGLQIZVGSZFOB-UHFFFAOYSA-N 0.000 description 1
- AJAOWKBTJKUMMA-UHFFFAOYSA-N 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-7-[5-[(4-fluoro-2-morpholin-4-ylsulfonylphenyl)methyl]-1,3-thiazol-2-yl]-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C(=CC(F)=CC=3)S(=O)(=O)N3CCOCC3)=CN=1)=C2OCC1=CC=CC=C1 AJAOWKBTJKUMMA-UHFFFAOYSA-N 0.000 description 1
- BKVYTKMFJXUMLM-UHFFFAOYSA-N 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-7-[5-[[4-fluoro-2-(morpholine-4-carbonyl)phenyl]methyl]-1,3-thiazol-2-yl]-6-hydroxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN1C2=NC(C=3SC(CC=4C(=CC(F)=CC=4)C(=O)N4CCOCC4)=CN=3)=C(O)C(=O)N2C=C1 BKVYTKMFJXUMLM-UHFFFAOYSA-N 0.000 description 1
- AQYGGVDCPKEFDR-UHFFFAOYSA-N 1-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CC1CCCCN1C(=O)CN(C=CN1C2=O)C1=NC(C(O)=O)=C2OCC1=CC=CC=C1 AQYGGVDCPKEFDR-UHFFFAOYSA-N 0.000 description 1
- YVANFFFSLINTGJ-UHFFFAOYSA-N 1-[2-(3,5-dimethylpiperidin-1-yl)-2-oxoethyl]-n-[[2-(dimethylsulfamoyl)-4-fluorophenyl]methyl]-6-hydroxy-3-(methylsulfanylmethyl)-5-oxoimidazo[1,2-a]pyrimidine-7-carboxamide Chemical compound C12=NC(C(=O)NCC=3C(=CC(F)=CC=3)S(=O)(=O)N(C)C)=C(O)C(=O)N2C(CSC)=CN1CC(=O)N1CC(C)CC(C)C1 YVANFFFSLINTGJ-UHFFFAOYSA-N 0.000 description 1
- FTAMCMSYWHFNFM-UHFFFAOYSA-N 1-[2-(3,5-dimethylpiperidin-1-yl)-2-oxoethyl]-n-[[2-(dimethylsulfamoyl)-4-fluorophenyl]methyl]-6-hydroxy-3-(methylsulfonylmethyl)-5-oxoimidazo[1,2-a]pyrimidine-7-carboxamide Chemical compound C1C(C)CC(C)CN1C(=O)CN1C2=NC(C(=O)NCC=3C(=CC(F)=CC=3)S(=O)(=O)N(C)C)=C(O)C(=O)N2C(CS(C)(=O)=O)=C1 FTAMCMSYWHFNFM-UHFFFAOYSA-N 0.000 description 1
- LIKMNXDESCEULM-UHFFFAOYSA-N 1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carbothioic s-acid Chemical compound C1CC(C)CCN1C(=O)CN(C=CN1C2=O)C1=NC(C(O)=S)=C2OCC1=CC=CC=C1 LIKMNXDESCEULM-UHFFFAOYSA-N 0.000 description 1
- KLYWFWHIQDOLPU-XYPWUTKMSA-N 1-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-oxoethyl]-7-[5-[1-(4-fluorophenyl)ethyl]-1,3-thiazol-2-yl]-6-hydroxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C=1C=C(F)C=CC=1C(C)C(S1)=CN=C1C(=C(C(=O)N1C=C2)O)N=C1N2CC(=O)N1C[C@H](C)O[C@H](C)C1 KLYWFWHIQDOLPU-XYPWUTKMSA-N 0.000 description 1
- YKCRDJMESWOGTQ-CBQGHPETSA-N 1-[2-[(2r,6s)-2,6-dimethylmorpholin-4-yl]-2-oxoethyl]-7-[5-[1-(4-fluorophenyl)ethyl]-1,3-thiazol-2-yl]-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C=1C=C(F)C=CC=1C(C)C(S1)=CN=C1C(=C(C(=O)N1C=C2)OCC=3C=CC=CC=3)N=C1N2CC(=O)N1C[C@H](C)O[C@H](C)C1 YKCRDJMESWOGTQ-CBQGHPETSA-N 0.000 description 1
- LXSXUBGQHHOITP-UHFFFAOYSA-N 1-[2-[4-(2,2-dimethylpropanoyl)piperazin-1-yl]-2-oxoethyl]-7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-6-hydroxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1CN(C(=O)C(C)(C)C)CCN1C(=O)CN1C2=NC(C=3SC(CC=4C=CC(F)=CC=4)=CN=3)=C(O)C(=O)N2C=C1 LXSXUBGQHHOITP-UHFFFAOYSA-N 0.000 description 1
- ADDUHUFTSBIRHA-UHFFFAOYSA-N 1-amino-3-(3,4-dichlorophenyl)propan-2-one;hydrochloride Chemical compound Cl.NCC(=O)CC1=CC=C(Cl)C(Cl)=C1 ADDUHUFTSBIRHA-UHFFFAOYSA-N 0.000 description 1
- WDACZQUSMOYTCC-UHFFFAOYSA-N 1-amino-3-(4-chloro-3-fluorophenyl)propan-2-one;hydrochloride Chemical compound Cl.NCC(=O)CC1=CC=C(Cl)C(F)=C1 WDACZQUSMOYTCC-UHFFFAOYSA-N 0.000 description 1
- SJCIHQQOGFBHTO-UHFFFAOYSA-N 1-amino-3-(4-chlorophenyl)propan-2-one;hydrochloride Chemical compound Cl.NCC(=O)CC1=CC=C(Cl)C=C1 SJCIHQQOGFBHTO-UHFFFAOYSA-N 0.000 description 1
- JFXDUAWJIMUJQN-UHFFFAOYSA-N 1-chloro-3-(4-fluorophenyl)propan-2-one Chemical compound FC1=CC=C(CC(=O)CCl)C=C1 JFXDUAWJIMUJQN-UHFFFAOYSA-N 0.000 description 1
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical class CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
- KGNQDBQYEBMPFZ-UHFFFAOYSA-N 1-fluoro-4-iodobenzene Chemical compound FC1=CC=C(I)C=C1 KGNQDBQYEBMPFZ-UHFFFAOYSA-N 0.000 description 1
- VIPWUFMFHBIKQI-UHFFFAOYSA-N 1-fluoro-4-methoxybenzene Chemical compound COC1=CC=C(F)C=C1 VIPWUFMFHBIKQI-UHFFFAOYSA-N 0.000 description 1
- HLIPNOCMUMHICC-UHFFFAOYSA-N 1-methyl-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxylic acid Chemical compound CN1C=CN(C2=O)C1=NC(C(O)=O)=C2OCC1=CC=CC=C1 HLIPNOCMUMHICC-UHFFFAOYSA-N 0.000 description 1
- FPXSBUFYJKLUNR-UHFFFAOYSA-N 1-n,1-n,2-n,2-n-tetramethylnaphthalene-1,2-diamine Chemical compound C1=CC=CC2=C(N(C)C)C(N(C)C)=CC=C21 FPXSBUFYJKLUNR-UHFFFAOYSA-N 0.000 description 1
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
- WLODWTPNUWYZKN-UHFFFAOYSA-N 1h-pyrrol-2-ol Chemical compound OC1=CC=CN1 WLODWTPNUWYZKN-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- LFEXGBPVZBXATF-UHFFFAOYSA-N 2,3-dimethylbenzenesulfonamide Chemical compound CC1=CC=CC(S(N)(=O)=O)=C1C LFEXGBPVZBXATF-UHFFFAOYSA-N 0.000 description 1
- RJXOVESYJFXCGI-UHFFFAOYSA-N 2,4-difluoro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1F RJXOVESYJFXCGI-UHFFFAOYSA-N 0.000 description 1
- HNVIQLPOGUDBSU-UHFFFAOYSA-N 2,6-dimethylmorpholine Chemical compound CC1CNCC(C)O1 HNVIQLPOGUDBSU-UHFFFAOYSA-N 0.000 description 1
- RKPBZUIKMMRYSW-UHFFFAOYSA-N 2-(2-bromo-3-oxopropyl)-5-fluoro-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC(F)=CC=C1CC(Br)C=O RKPBZUIKMMRYSW-UHFFFAOYSA-N 0.000 description 1
- IDBYHCGSWMSFLY-UHFFFAOYSA-N 2-(4-chloro-3-fluorophenyl)acetonitrile Chemical compound FC1=CC(CC#N)=CC=C1Cl IDBYHCGSWMSFLY-UHFFFAOYSA-N 0.000 description 1
- CZENAQJPTMNCQL-UHFFFAOYSA-N 2-(4-chloro-3-fluorophenyl)acetyl chloride Chemical compound FC1=CC(CC(Cl)=O)=CC=C1Cl CZENAQJPTMNCQL-UHFFFAOYSA-N 0.000 description 1
- SIOJFYRPBYGHOO-UHFFFAOYSA-N 2-(4-fluorophenyl)acetyl chloride Chemical compound FC1=CC=C(CC(Cl)=O)C=C1 SIOJFYRPBYGHOO-UHFFFAOYSA-N 0.000 description 1
- VMJOGHYLJSXTDW-UHFFFAOYSA-N 2-(bromomethyl)-1,3-thiazole Chemical compound BrCC1=NC=CS1 VMJOGHYLJSXTDW-UHFFFAOYSA-N 0.000 description 1
- GPEQJCSWZJLTLQ-UHFFFAOYSA-N 2-(bromomethyl)-5-fluoro-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC(F)=CC=C1CBr GPEQJCSWZJLTLQ-UHFFFAOYSA-N 0.000 description 1
- HLQVZHNALYETGB-UHFFFAOYSA-N 2-(cyanomethyl)-5-fluoro-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC(F)=CC=C1CC#N HLQVZHNALYETGB-UHFFFAOYSA-N 0.000 description 1
- WCASXYBKJHWFMY-NSCUHMNNSA-N 2-Buten-1-ol Chemical compound C\C=C\CO WCASXYBKJHWFMY-NSCUHMNNSA-N 0.000 description 1
- AKYGWAMDWBOABX-UHFFFAOYSA-N 2-[[2-[1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-4-oxo-5-phenylmethoxy-3ah-indol-6-yl]-1,3-thiazol-5-yl]methyl]-5-fluorobenzoic acid Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CC1C2=O)C1=CC(C=1SC(CC=3C(=CC(F)=CC=3)C(O)=O)=CN=1)=C2OCC1=CC=CC=C1 AKYGWAMDWBOABX-UHFFFAOYSA-N 0.000 description 1
- MILNSDXRYZPPLH-UHFFFAOYSA-N 2-[[2-[1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]-5-fluoro-n,n-dimethylbenzamide Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C(=CC(F)=CC=3)C(=O)N(C)C)=CN=1)=C2OCC1=CC=CC=C1 MILNSDXRYZPPLH-UHFFFAOYSA-N 0.000 description 1
- XCBMSUIZXDYWFU-UHFFFAOYSA-N 2-[[2-[1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]-5-fluoro-n,n-dimethylbenzenesulfonamide Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C(=CC(F)=CC=3)S(=O)(=O)N(C)C)=CN=1)=C2OCC1=CC=CC=C1 XCBMSUIZXDYWFU-UHFFFAOYSA-N 0.000 description 1
- BSPLLHZTNSQQNF-UHFFFAOYSA-N 2-[[2-[1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-hydroxy-5-oxoimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]-5-fluoro-N,N-dimethylbenzamide Chemical compound C1C(C)OC(C)CN1C(=O)CN1C2=NC(C=3SC(CC=4C(=CC(F)=CC=4)C(=O)N(C)C)=CN=3)=C(O)C(=O)N2C=C1 BSPLLHZTNSQQNF-UHFFFAOYSA-N 0.000 description 1
- GNMRIVZDOWWYLI-UHFFFAOYSA-N 2-[[2-[1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-hydroxy-5-oxoimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]-5-fluoro-N,N-dimethylbenzenesulfonamide Chemical compound C1C(C)OC(C)CN1C(=O)CN1C2=NC(C=3SC(CC=4C(=CC(F)=CC=4)S(=O)(=O)N(C)C)=CN=3)=C(O)C(=O)N2C=C1 GNMRIVZDOWWYLI-UHFFFAOYSA-N 0.000 description 1
- QWXXVPLPLHLXJY-UHFFFAOYSA-N 2-[[2-[1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-hydroxy-5-oxoimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]-5-fluoro-N-propan-2-ylbenzamide Chemical compound CC(C)NC(=O)C1=CC(F)=CC=C1CC1=CN=C(C2=C(C(=O)N3C=CN(CC(=O)N4CC(C)OC(C)C4)C3=N2)O)S1 QWXXVPLPLHLXJY-UHFFFAOYSA-N 0.000 description 1
- SZHMRZAAOIXVGH-GASCZTMLSA-N 2-[[2-[1-[2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-oxoethyl]-6-hydroxy-5-oxoimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]-5-fluorobenzonitrile Chemical compound C1[C@@H](C)O[C@@H](C)CN1C(=O)CN1C2=NC(C=3SC(CC=4C(=CC(F)=CC=4)C#N)=CN=3)=C(O)C(=O)N2C=C1 SZHMRZAAOIXVGH-GASCZTMLSA-N 0.000 description 1
- XBNMHGZYKYVLID-UHFFFAOYSA-N 2-bromo-1-(3,5-dimethylpiperidin-1-yl)ethanone Chemical compound CC1CC(C)CN(C(=O)CBr)C1 XBNMHGZYKYVLID-UHFFFAOYSA-N 0.000 description 1
- AYOIGGLZHNDMFA-UHFFFAOYSA-N 2-bromo-3-(3,4-dichlorophenyl)propanal Chemical compound ClC1=CC=C(CC(Br)C=O)C=C1Cl AYOIGGLZHNDMFA-UHFFFAOYSA-N 0.000 description 1
- WAZQRVJYRGKCKR-UHFFFAOYSA-N 2-bromo-3-(3-chloro-4-fluorophenyl)propanal Chemical compound FC1=CC=C(CC(Br)C=O)C=C1Cl WAZQRVJYRGKCKR-UHFFFAOYSA-N 0.000 description 1
- OWBXOZHADHREPV-UHFFFAOYSA-N 2-bromo-3-(4-fluoro-2-methylsulfonylphenyl)propanal Chemical compound CS(=O)(=O)C1=CC(F)=CC=C1CC(Br)C=O OWBXOZHADHREPV-UHFFFAOYSA-N 0.000 description 1
- WPNANGZVPFJPNZ-UHFFFAOYSA-N 2-bromo-3-phenylpropanal Chemical compound O=CC(Br)CC1=CC=CC=C1 WPNANGZVPFJPNZ-UHFFFAOYSA-N 0.000 description 1
- SMTSEWHPTUIWBY-UHFFFAOYSA-N 2-chloro-1-(2,6-dimethylmorpholin-4-yl)ethanone Chemical compound CC1CN(C(=O)CCl)CC(C)O1 SMTSEWHPTUIWBY-UHFFFAOYSA-N 0.000 description 1
- WCZCFIKPRBDVOM-UHFFFAOYSA-N 2-chloro-1-(2-methylpiperidin-1-yl)ethanone Chemical compound CC1CCCCN1C(=O)CCl WCZCFIKPRBDVOM-UHFFFAOYSA-N 0.000 description 1
- NWGYRQNLZDGOQG-UHFFFAOYSA-N 2-chloro-1-(4-methylpiperidin-1-yl)ethanone Chemical compound CC1CCN(C(=O)CCl)CC1 NWGYRQNLZDGOQG-UHFFFAOYSA-N 0.000 description 1
- OMASDGWBVAVFQZ-UHFFFAOYSA-N 2-chloro-1-fluoro-4-iodobenzene Chemical compound FC1=CC=C(I)C=C1Cl OMASDGWBVAVFQZ-UHFFFAOYSA-N 0.000 description 1
- NSWLMOHUXYULKL-UHFFFAOYSA-N 2-chloro-1-piperidin-1-ylethanone Chemical compound ClCC(=O)N1CCCCC1 NSWLMOHUXYULKL-UHFFFAOYSA-N 0.000 description 1
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- VZWOXDYRBDIHMA-UHFFFAOYSA-N 2-methyl-1,3-thiazole Chemical compound CC1=NC=CS1 VZWOXDYRBDIHMA-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IDWRJRPUIXRFRX-UHFFFAOYSA-N 3,5-dimethylpiperidine Chemical compound CC1CNCC(C)C1 IDWRJRPUIXRFRX-UHFFFAOYSA-N 0.000 description 1
- UBUQWRXGPBSBSK-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)propanal Chemical compound ClC1=CC=C(CCC=O)C=C1Cl UBUQWRXGPBSBSK-UHFFFAOYSA-N 0.000 description 1
- RUZDLPUZAMKBMP-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)propanal Chemical compound FC1=CC=C(CCC=O)C=C1Cl RUZDLPUZAMKBMP-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- GCEWHSNVFKLOBM-UHFFFAOYSA-N 3-(4-fluoro-2-methylsulfanylphenyl)propanal Chemical compound CSC1=CC(F)=CC=C1CCC=O GCEWHSNVFKLOBM-UHFFFAOYSA-N 0.000 description 1
- OBFAPXAMZKJBSF-UHFFFAOYSA-N 3-(4-fluoro-2-methylsulfonylphenyl)propan-1-ol Chemical compound CS(=O)(=O)C1=CC(F)=CC=C1CCCO OBFAPXAMZKJBSF-UHFFFAOYSA-N 0.000 description 1
- NEXBGLGTFSJUEO-UHFFFAOYSA-N 3-(4-fluoro-2-methylsulfonylphenyl)propanal Chemical compound CS(=O)(=O)C1=CC(F)=CC=C1CCC=O NEXBGLGTFSJUEO-UHFFFAOYSA-N 0.000 description 1
- QZXPSIARJQTDNQ-UHFFFAOYSA-N 3-(4-fluorophenyl)propanal Chemical compound FC1=CC=C(CCC=O)C=C1 QZXPSIARJQTDNQ-UHFFFAOYSA-N 0.000 description 1
- BRMWTNUJHUMWMS-UHFFFAOYSA-N 3-Methylhistidine Natural products CN1C=NC(CC(N)C(O)=O)=C1 BRMWTNUJHUMWMS-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- YMUKZZSMBMJJIL-UHFFFAOYSA-N 3-bromo-3-(4-fluorophenyl)propanal Chemical compound FC1=CC=C(C(Br)CC=O)C=C1 YMUKZZSMBMJJIL-UHFFFAOYSA-N 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
- PRZDTXCINYQIDW-UHFFFAOYSA-N 5-fluoro-2-hydroxy-n,n-dimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC(F)=CC=C1O PRZDTXCINYQIDW-UHFFFAOYSA-N 0.000 description 1
- XPFMQYOPTHMSJJ-UHFFFAOYSA-N 5-fluoro-2-iodobenzoic acid Chemical compound OC(=O)C1=CC(F)=CC=C1I XPFMQYOPTHMSJJ-UHFFFAOYSA-N 0.000 description 1
- UMQIWDPHGSATQR-UHFFFAOYSA-N 5-fluoro-2-methoxy-n,n-dimethylbenzenesulfonamide Chemical compound COC1=CC=C(F)C=C1S(=O)(=O)N(C)C UMQIWDPHGSATQR-UHFFFAOYSA-N 0.000 description 1
- LUEBMKPHZDSPFH-UHFFFAOYSA-N 5-fluoro-2-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(F)C=C1S(Cl)(=O)=O LUEBMKPHZDSPFH-UHFFFAOYSA-N 0.000 description 1
- NPEWBMJAUUSBLE-UHFFFAOYSA-N 5-fluoro-2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=C(F)C=C1S(Cl)(=O)=O NPEWBMJAUUSBLE-UHFFFAOYSA-N 0.000 description 1
- NHOBYURJJKNOFU-UHFFFAOYSA-N 5-fluoro-n,n,2-trimethylbenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC(F)=CC=C1C NHOBYURJJKNOFU-UHFFFAOYSA-N 0.000 description 1
- LFAHHHHMBXZUBS-UHFFFAOYSA-N 5-fluoro-n,n-dimethyl-2-(3-oxopropyl)benzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC(F)=CC=C1CCC=O LFAHHHHMBXZUBS-UHFFFAOYSA-N 0.000 description 1
- FPQMGQZTBWIHDN-UHFFFAOYSA-N 5-fluoroanthranilic acid Chemical compound NC1=CC=C(F)C=C1C(O)=O FPQMGQZTBWIHDN-UHFFFAOYSA-N 0.000 description 1
- NFTVDUBWXUGQPG-UHFFFAOYSA-N 5-oxo-1-(2-oxo-2-piperidin-1-ylethyl)-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carbothioic s-acid Chemical compound C1=CN2C(=O)C(OCC=3C=CC=CC=3)=C(C(=S)O)N=C2N1CC(=O)N1CCCCC1 NFTVDUBWXUGQPG-UHFFFAOYSA-N 0.000 description 1
- XZLHDJFTPJFACZ-UHFFFAOYSA-N 5-oxo-1-(2-oxo-2-piperidin-1-ylethyl)-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1=CN2C(=O)C(OCC=3C=CC=CC=3)=C(C(=O)O)N=C2N1CC(=O)N1CCCCC1 XZLHDJFTPJFACZ-UHFFFAOYSA-N 0.000 description 1
- IWAXVVYVNFKHDR-UHFFFAOYSA-N 5-oxo-6-phenylmethoxy-1-(1,3-thiazol-2-ylmethyl)imidazo[1,2-a]pyrimidine-7-carboxylic acid Chemical compound C1=CN2C(=O)C(OCC=3C=CC=CC=3)=C(C(=O)O)N=C2N1CC1=NC=CS1 IWAXVVYVNFKHDR-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- SEJNDLOSTRAXKO-UHFFFAOYSA-N 7-[5-[(3,4-dichlorophenyl)methyl]-1,3-thiazol-2-yl]-1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-hydroxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN1C2=NC(C=3SC(CC=4C=C(Cl)C(Cl)=CC=4)=CN=3)=C(O)C(=O)N2C=C1 SEJNDLOSTRAXKO-UHFFFAOYSA-N 0.000 description 1
- HXHRTVFHHINJCB-UHFFFAOYSA-N 7-[5-[(3,4-dichlorophenyl)methyl]-1,3-thiazol-2-yl]-1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C=C(Cl)C(Cl)=CC=3)=CN=1)=C2OCC1=CC=CC=C1 HXHRTVFHHINJCB-UHFFFAOYSA-N 0.000 description 1
- OTFLFHZTMAJPPR-UHFFFAOYSA-N 7-[5-[(3,4-dichlorophenyl)methyl]-1,3-thiazol-2-yl]-1-methyl-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound CN1C=CN(C(C=2OCC=3C=CC=CC=3)=O)C1=NC=2C(S1)=NC=C1CC1=CC=C(Cl)C(Cl)=C1 OTFLFHZTMAJPPR-UHFFFAOYSA-N 0.000 description 1
- FLEFKEQNOIAENI-UHFFFAOYSA-N 7-[5-[(3,4-dichlorophenyl)methyl]-1,3-thiazol-2-yl]-6-hydroxy-1-methylimidazo[1,2-a]pyrimidin-5-one Chemical compound CN1C=CN(C(C=2O)=O)C1=NC=2C(S1)=NC=C1CC1=CC=C(Cl)C(Cl)=C1 FLEFKEQNOIAENI-UHFFFAOYSA-N 0.000 description 1
- YIGMAEJVKONEGT-UHFFFAOYSA-N 7-[5-[(3-chloro-4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-hydroxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN1C2=NC(C=3SC(CC=4C=C(Cl)C(F)=CC=4)=CN=3)=C(O)C(=O)N2C=C1 YIGMAEJVKONEGT-UHFFFAOYSA-N 0.000 description 1
- KXUMSUIYNHKIDL-UHFFFAOYSA-N 7-[5-[(3-chloro-4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C=C(Cl)C(F)=CC=3)=CN=1)=C2OCC1=CC=CC=C1 KXUMSUIYNHKIDL-UHFFFAOYSA-N 0.000 description 1
- QJNKFVVGYPPEPH-UHFFFAOYSA-N 7-[5-[(4-chloro-3-fluorophenyl)methyl]-1,3-thiazol-2-yl]-1-methyl-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound CN1C=CN(C(C=2OCC=3C=CC=CC=3)=O)C1=NC=2C(S1)=NC=C1CC1=CC=C(Cl)C(F)=C1 QJNKFVVGYPPEPH-UHFFFAOYSA-N 0.000 description 1
- DTCFPNBRHKBGAD-UHFFFAOYSA-N 7-[5-[(4-chlorophenyl)methyl]-1,3-thiazol-2-yl]-1-methyl-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound CN1C=CN(C(C=2OCC=3C=CC=CC=3)=O)C1=NC=2C(S1)=NC=C1CC1=CC=C(Cl)C=C1 DTCFPNBRHKBGAD-UHFFFAOYSA-N 0.000 description 1
- ILMKJRDFDFFRJM-UHFFFAOYSA-N 7-[5-[(4-chlorophenyl)methyl]-1,3-thiazol-2-yl]-6-hydroxy-1-methylimidazo[1,2-a]pyrimidin-5-one Chemical compound CN1C=CN(C(C=2O)=O)C1=NC=2C(S1)=NC=C1CC1=CC=C(Cl)C=C1 ILMKJRDFDFFRJM-UHFFFAOYSA-N 0.000 description 1
- HHMMCFUGQSHOPT-UHFFFAOYSA-N 7-[5-[(4-fluorophenyl)methyl]-1,3-oxazol-2-yl]-1-(2-oxo-2-piperidin-1-ylethyl)-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound C1=CC(F)=CC=C1CC1=CN=C(C2=C(C(=O)N3C=CN(CC(=O)N4CCCCC4)C3=N2)OCC=2C=CC=CC=2)O1 HHMMCFUGQSHOPT-UHFFFAOYSA-N 0.000 description 1
- JPKUZKPQTZTZJB-UHFFFAOYSA-N 7-[5-[(4-fluorophenyl)methyl]-1,3-oxazol-2-yl]-6-hydroxy-1-(2-oxo-2-piperidin-1-ylethyl)imidazo[1,2-a]pyrimidin-5-one Chemical compound C1=CN2C(=O)C(O)=C(C=3OC(CC=4C=CC(F)=CC=4)=CN=3)N=C2N1CC(=O)N1CCCCC1 JPKUZKPQTZTZJB-UHFFFAOYSA-N 0.000 description 1
- IUMZWVPQQLJUAZ-UHFFFAOYSA-N 7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-1-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound CC1CCCCN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C=CC(F)=CC=3)=CN=1)=C2OCC1=CC=CC=C1 IUMZWVPQQLJUAZ-UHFFFAOYSA-N 0.000 description 1
- BSRAJTXUBOTVMB-UHFFFAOYSA-N 7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-1-methyl-6-phenylmethoxyimidazo[1,2-a]pyrimidin-5-one Chemical compound CN1C=CN(C(C=2OCC=3C=CC=CC=3)=O)C1=NC=2C(S1)=NC=C1CC1=CC=C(F)C=C1 BSRAJTXUBOTVMB-UHFFFAOYSA-N 0.000 description 1
- KPOIKESWRLRVMT-UHFFFAOYSA-N 7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-6-hydroxy-1-(1-methyl-2-oxopyrrolidin-3-yl)imidazo[1,2-a]pyrimidin-5-one Chemical compound O=C1N(C)CCC1N1C2=NC(C=3SC(CC=4C=CC(F)=CC=4)=CN=3)=C(O)C(=O)N2C=C1 KPOIKESWRLRVMT-UHFFFAOYSA-N 0.000 description 1
- FJAXWRWARQTPOS-UHFFFAOYSA-N 7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-6-hydroxy-1-(2-oxo-2-piperazin-1-ylethyl)imidazo[1,2-a]pyrimidin-5-one Chemical compound C1=CN2C(=O)C(O)=C(C=3SC(CC=4C=CC(F)=CC=4)=CN=3)N=C2N1CC(=O)N1CCNCC1 FJAXWRWARQTPOS-UHFFFAOYSA-N 0.000 description 1
- PCDLRIUITBETIM-UHFFFAOYSA-N 7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-6-hydroxy-1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]imidazo[1,2-a]pyrimidin-5-one Chemical compound C1CC(C)CCN1C(=O)CN1C2=NC(C=3SC(CC=4C=CC(F)=CC=4)=CN=3)=C(O)C(=O)N2C=C1 PCDLRIUITBETIM-UHFFFAOYSA-N 0.000 description 1
- OJCUNMYQOHPFHT-UHFFFAOYSA-N 7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-6-phenylmethoxy-1-(1,3-thiazol-2-ylmethyl)imidazo[1,2-a]pyrimidin-5-one Chemical compound C1=CC(F)=CC=C1CC1=CN=C(C2=C(C(=O)N3C=CN(CC=4SC=CN=4)C3=N2)OCC=2C=CC=CC=2)S1 OJCUNMYQOHPFHT-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- YCIPQJTZJGUXND-UHFFFAOYSA-N Aglaia odorata Alkaloid Natural products C1=CC(OC)=CC=C1C1(C(C=2C(=O)N3CCCC3=NC=22)C=3C=CC=CC=3)C2(O)C2=C(OC)C=C(OC)C=C2O1 YCIPQJTZJGUXND-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 102100038916 Caspase-5 Human genes 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229910015400 FeC13 Inorganic materials 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229910004373 HOAc Inorganic materials 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101100112336 Homo sapiens CASP5 gene Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- UCUNFLYVYCGDHP-BYPYZUCNSA-N L-methionine sulfone Chemical compound CS(=O)(=O)CC[C@H](N)C(O)=O UCUNFLYVYCGDHP-BYPYZUCNSA-N 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- 229910013596 LiOH—H2O Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 240000005265 Lupinus mutabilis Species 0.000 description 1
- 235000008755 Lupinus mutabilis Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229940124528 MK-2048 Drugs 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000714177 Murine leukemia virus Species 0.000 description 1
- 101100273286 Mus musculus Casp4 gene Proteins 0.000 description 1
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- XKTJTUVQKOYBFR-UHFFFAOYSA-N N-cyclopropyl-2-[[2-[1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-hydroxy-5-oxoimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]-5-fluorobenzamide Chemical compound C1C(C)OC(C)CN1C(=O)CN1C2=NC(C=3SC(CC=4C(=CC(F)=CC=4)C(=O)NC4CC4)=CN=3)=C(O)C(=O)N2C=C1 XKTJTUVQKOYBFR-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 101000762440 Pseudophryne guentheri Bombesin-like peptide L Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000005726 Robinson-Gabriel synthesis reaction Methods 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 235000019095 Sechium edule Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 238000005874 Vilsmeier-Haack formylation reaction Methods 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- ITBRPZLROZDEJC-UHFFFAOYSA-N [2-(dimethylsulfamoyl)-4-fluorophenyl] trifluoromethanesulfonate Chemical compound CN(C)S(=O)(=O)C1=CC(F)=CC=C1OS(=O)(=O)C(F)(F)F ITBRPZLROZDEJC-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- AMTCKRZHSPPHSE-UHFFFAOYSA-N [N-]=[N+]=NON=[N+]=[N-] Chemical compound [N-]=[N+]=NON=[N+]=[N-] AMTCKRZHSPPHSE-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- IYYIVELXUANFED-UHFFFAOYSA-N bromo(trimethyl)silane Chemical compound C[Si](C)(C)Br IYYIVELXUANFED-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- NMGFRGWSRHOQOP-UHFFFAOYSA-N carbamic acid;urea Chemical compound NC(N)=O.NC(O)=O NMGFRGWSRHOQOP-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 150000008050 dialkyl sulfates Chemical class 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- FPULFENIJDPZBX-UHFFFAOYSA-N ethyl 2-isocyanoacetate Chemical compound CCOC(=O)C[N+]#[C-] FPULFENIJDPZBX-UHFFFAOYSA-N 0.000 description 1
- 125000004672 ethylcarbonyl group Chemical group [H]C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004175 fluorobenzyl group Chemical group 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N hydroxymaleic acid group Chemical group O/C(/C(=O)O)=C/C(=O)O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940124525 integrase strand transfer inhibitor Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- VSVFBZIHNSOQIJ-UHFFFAOYSA-N methyl 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OCC=3C=CC=CC=3)=C(C(=O)OC)N=C2N1CC(=O)N1CC(C)OC(C)C1 VSVFBZIHNSOQIJ-UHFFFAOYSA-N 0.000 description 1
- HLBPOTUHZZFHRI-UHFFFAOYSA-N methyl 1-[2-(3,5-dimethylpiperidin-1-yl)-2-oxoethyl]-6-hydroxy-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(O)=C(C(=O)OC)N=C2N1CC(=O)N1CC(C)CC(C)C1 HLBPOTUHZZFHRI-UHFFFAOYSA-N 0.000 description 1
- BSAXACJKXSTMSC-UHFFFAOYSA-N methyl 1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OCC=3C=CC=CC=3)=C(C(=O)OC)N=C2N1CC(=O)N1CCC(C)CC1 BSAXACJKXSTMSC-UHFFFAOYSA-N 0.000 description 1
- YJWGTNTYXLSYLM-UHFFFAOYSA-N methyl 2-(2-bromo-3-oxopropyl)benzoate Chemical compound COC(=O)C1=CC=CC=C1CC(Br)C=O YJWGTNTYXLSYLM-UHFFFAOYSA-N 0.000 description 1
- HLPUZROXLULFFL-UHFFFAOYSA-N methyl 2-[[2-[1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-6-hydroxy-5-oxoimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]-5-fluorobenzoate Chemical compound COC(=O)C1=CC(F)=CC=C1CC1=CN=C(C2=C(C(=O)N3C=CN(CC(=O)N4CC(C)OC(C)C4)C3=N2)O)S1 HLPUZROXLULFFL-UHFFFAOYSA-N 0.000 description 1
- KYMZTJZNCSYYRO-UHFFFAOYSA-N methyl 2-[[2-[5-oxo-1-(2-oxo-2-piperidin-1-ylethyl)-6-phenylmethoxyimidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]benzoate Chemical compound COC(=O)C1=CC=CC=C1CC1=CN=C(C2=C(C(=O)N3C=CN(CC(=O)N4CCCCC4)C3=N2)OCC=2C=CC=CC=2)S1 KYMZTJZNCSYYRO-UHFFFAOYSA-N 0.000 description 1
- WVQWSUBGQYTHES-UHFFFAOYSA-N methyl 2-[[2-[6-hydroxy-5-oxo-1-(2-oxo-2-piperidin-1-ylethyl)imidazo[1,2-a]pyrimidin-7-yl]-1,3-thiazol-5-yl]methyl]benzoate Chemical compound COC(=O)C1=CC=CC=C1CC1=CN=C(C2=C(C(=O)N3C=CN(CC(=O)N4CCCCC4)C3=N2)O)S1 WVQWSUBGQYTHES-UHFFFAOYSA-N 0.000 description 1
- BXXLTVBTDZXPTN-UHFFFAOYSA-N methyl 2-iodobenzoate Chemical compound COC(=O)C1=CC=CC=C1I BXXLTVBTDZXPTN-UHFFFAOYSA-N 0.000 description 1
- UTEMHQAGNZTRMZ-UHFFFAOYSA-N methyl 3-(4-fluoro-2-methylsulfonylphenyl)propanoate Chemical compound COC(=O)CCC1=CC=C(F)C=C1S(C)(=O)=O UTEMHQAGNZTRMZ-UHFFFAOYSA-N 0.000 description 1
- WUJSMHUCQVMXJF-UHFFFAOYSA-N methyl 3-(4-fluoro-2-morpholin-4-ylsulfonylphenyl)propanoate Chemical compound COC(=O)CCC1=CC=C(F)C=C1S(=O)(=O)N1CCOCC1 WUJSMHUCQVMXJF-UHFFFAOYSA-N 0.000 description 1
- OLPQEVGZOOVHBX-UHFFFAOYSA-N methyl 3-[2-(dimethylsulfamoyl)-4-fluorophenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(F)C=C1S(=O)(=O)N(C)C OLPQEVGZOOVHBX-UHFFFAOYSA-N 0.000 description 1
- KRWWZOLXINPOPI-UHFFFAOYSA-N methyl 3-bromo-1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=C(Br)N2C(=O)C(OCC=3C=CC=CC=3)=C(C(=O)OC)N=C2N1CC(=O)N1CC(C)OC(C)C1 KRWWZOLXINPOPI-UHFFFAOYSA-N 0.000 description 1
- DTIWOKISOJGBOZ-UHFFFAOYSA-N methyl 5-oxo-6-phenylmethoxy-1-(1,3-thiazol-2-ylmethyl)imidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OCC=3C=CC=CC=3)=C(C(=O)OC)N=C2N1CC1=NC=CS1 DTIWOKISOJGBOZ-UHFFFAOYSA-N 0.000 description 1
- JXOGLNRSRKNWKN-UHFFFAOYSA-N methyl 6-acetyloxy-1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OC(C)=O)=C(C(=O)OC)N=C2N1CC(=O)N1CC(C)OC(C)C1 JXOGLNRSRKNWKN-UHFFFAOYSA-N 0.000 description 1
- YBVVHHULAHCSJO-UHFFFAOYSA-N methyl 6-acetyloxy-1-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OC(C)=O)=C(C(=O)OC)N=C2N1CC(=O)N1CCCCC1C YBVVHHULAHCSJO-UHFFFAOYSA-N 0.000 description 1
- FKFMMVNYDCXYEB-UHFFFAOYSA-N methyl 6-acetyloxy-1-[2-(3,5-dimethylpiperidin-1-yl)-2-oxoethyl]-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OC(C)=O)=C(C(=O)OC)N=C2N1CC(=O)N1CC(C)CC(C)C1 FKFMMVNYDCXYEB-UHFFFAOYSA-N 0.000 description 1
- DIEXDDRUGFMFBM-UHFFFAOYSA-N methyl 6-acetyloxy-1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OC(C)=O)=C(C(=O)OC)N=C2N1CC(=O)N1CCC(C)CC1 DIEXDDRUGFMFBM-UHFFFAOYSA-N 0.000 description 1
- JQDHYFJZADDNEB-UHFFFAOYSA-N methyl 6-acetyloxy-3-bromo-5-oxo-8h-imidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound O=C1C(OC(C)=O)=C(C(=O)OC)N=C2NC=C(Br)N21 JQDHYFJZADDNEB-UHFFFAOYSA-N 0.000 description 1
- SETKABOLLQPHLA-UHFFFAOYSA-N methyl 6-acetyloxy-5-oxo-1-(1,3-thiazol-2-ylmethyl)imidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OC(C)=O)=C(C(=O)OC)N=C2N1CC1=NC=CS1 SETKABOLLQPHLA-UHFFFAOYSA-N 0.000 description 1
- DITFWHGWHLOLSL-UHFFFAOYSA-N methyl 6-acetyloxy-5-oxo-1-(2-oxo-2-piperidin-1-ylethyl)imidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(OC(C)=O)=C(C(=O)OC)N=C2N1CC(=O)N1CCCCC1 DITFWHGWHLOLSL-UHFFFAOYSA-N 0.000 description 1
- JCMLTZGHOCEHTJ-UHFFFAOYSA-N methyl 6-hydroxy-1-methyl-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound O=C1C(O)=C(C(=O)OC)N=C2N(C)C=CN21 JCMLTZGHOCEHTJ-UHFFFAOYSA-N 0.000 description 1
- YAGFTYALTGXOGX-UHFFFAOYSA-N methyl 6-hydroxy-5-oxo-1-(2-oxo-2-piperidin-1-ylethyl)imidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound C1=CN2C(=O)C(O)=C(C(=O)OC)N=C2N1CC(=O)N1CCCCC1 YAGFTYALTGXOGX-UHFFFAOYSA-N 0.000 description 1
- BZTSIIPAGGZYEF-UHFFFAOYSA-N methyl 6-methyl-5-oxo-8h-imidazo[1,2-a]pyrimidine-7-carboxylate Chemical compound O=C1C(C)=C(C(=O)OC)N=C2NC=CN21 BZTSIIPAGGZYEF-UHFFFAOYSA-N 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- HHQJWDKIRXRTLS-UHFFFAOYSA-N n'-bromobutanediamide Chemical compound NC(=O)CCC(=O)NBr HHQJWDKIRXRTLS-UHFFFAOYSA-N 0.000 description 1
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
- JPYJKOBSYFMRMU-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)methyl]-1-[2-(3,5-dimethylpiperidin-1-yl)-2-oxoethyl]-6-hydroxy-3-(methylsulfanylmethyl)-5-oxoimidazo[1,2-a]pyrimidine-7-carboxamide Chemical compound C12=NC(C(=O)NCC=3C=C(Cl)C(Cl)=CC=3)=C(O)C(=O)N2C(CSC)=CN1CC(=O)N1CC(C)CC(C)C1 JPYJKOBSYFMRMU-UHFFFAOYSA-N 0.000 description 1
- JILXNFRFIVEEJJ-UHFFFAOYSA-N n-[(3,4-dichlorophenyl)methyl]-1-[2-(3,5-dimethylpiperidin-1-yl)-2-oxoethyl]-6-hydroxy-3-(methylsulfonylmethyl)-5-oxoimidazo[1,2-a]pyrimidine-7-carboxamide Chemical compound C1C(C)CC(C)CN1C(=O)CN1C2=NC(C(=O)NCC=3C=C(Cl)C(Cl)=CC=3)=C(O)C(=O)N2C(CS(C)(=O)=O)=C1 JILXNFRFIVEEJJ-UHFFFAOYSA-N 0.000 description 1
- ZEXFRQWBHKHJNE-UHFFFAOYSA-N n-[3-(3,4-dichlorophenyl)-2-oxopropyl]-1-methyl-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxamide Chemical compound CN1C=CN(C(C=2OCC=3C=CC=CC=3)=O)C1=NC=2C(=O)NCC(=O)CC1=CC=C(Cl)C(Cl)=C1 ZEXFRQWBHKHJNE-UHFFFAOYSA-N 0.000 description 1
- KSRWTRMJCXLTBA-UHFFFAOYSA-N n-[3-(4-chloro-3-fluorophenyl)-2-oxopropyl]-1-methyl-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxamide Chemical compound CN1C=CN(C(C=2OCC=3C=CC=CC=3)=O)C1=NC=2C(=O)NCC(=O)CC1=CC=C(Cl)C(F)=C1 KSRWTRMJCXLTBA-UHFFFAOYSA-N 0.000 description 1
- JQBQELNDKPHSTG-UHFFFAOYSA-N n-[3-(4-chlorophenyl)-2-oxopropyl]-1-methyl-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carboxamide Chemical compound CN1C=CN(C(C=2OCC=3C=CC=CC=3)=O)C1=NC=2C(=O)NCC(=O)CC1=CC=C(Cl)C=C1 JQBQELNDKPHSTG-UHFFFAOYSA-N 0.000 description 1
- IFYDWYVPVAMGRO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NCCCN(C)C IFYDWYVPVAMGRO-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N pentanoic acid group Chemical class C(CCCC)(=O)O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- NAYYNDKKHOIIOD-UHFFFAOYSA-N phthalamide Chemical compound NC(=O)C1=CC=CC=C1C(N)=O NAYYNDKKHOIIOD-UHFFFAOYSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001184 polypeptide Chemical group 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Chemical group 0.000 description 1
- DOKHEARVIDLSFF-UHFFFAOYSA-N prop-1-en-1-ol Chemical compound CC=CO DOKHEARVIDLSFF-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- DTYCNUVODJFWIS-UHFFFAOYSA-N s-[1-(3,4-dichlorophenyl)-3-oxopropan-2-yl] 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carbothioate Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C(=O)SC(CC=1C=C(Cl)C(Cl)=CC=1)C=O)=C2OCC1=CC=CC=C1 DTYCNUVODJFWIS-UHFFFAOYSA-N 0.000 description 1
- PDPFVRINQSEKPD-UHFFFAOYSA-N s-[1-(4-fluoro-2-methylsulfonylphenyl)-3-oxopropan-2-yl] 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carbothioate Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C(=O)SC(CC=1C(=CC(F)=CC=1)S(C)(=O)=O)C=O)=C2OCC1=CC=CC=C1 PDPFVRINQSEKPD-UHFFFAOYSA-N 0.000 description 1
- FOTIFCGGIHYYJU-UHFFFAOYSA-N s-[1-(4-fluorophenyl)-3-oxopropan-2-yl] 1-[2-(2-methylpiperidin-1-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carbothioate Chemical compound CC1CCCCN1C(=O)CN(C=CN1C2=O)C1=NC(C(=O)SC(CC=1C=CC(F)=CC=1)C=O)=C2OCC1=CC=CC=C1 FOTIFCGGIHYYJU-UHFFFAOYSA-N 0.000 description 1
- HOXPXTBWLMKTLX-UHFFFAOYSA-N s-[1-[2-(dimethylsulfamoyl)-4-fluorophenyl]-3-oxopropan-2-yl] 1-[2-(2,6-dimethylmorpholin-4-yl)-2-oxoethyl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidine-7-carbothioate Chemical compound C1C(C)OC(C)CN1C(=O)CN(C=CN1C2=O)C1=NC(C(=O)SC(CC=1C(=CC(F)=CC=1)S(=O)(=O)N(C)C)C=O)=C2OCC1=CC=CC=C1 HOXPXTBWLMKTLX-UHFFFAOYSA-N 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- RMBAVIFYHOYIFM-UHFFFAOYSA-M sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- PUGUQINMNYINPK-UHFFFAOYSA-N tert-butyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(C(=O)CCl)CC1 PUGUQINMNYINPK-UHFFFAOYSA-N 0.000 description 1
- FRAIEGKCMCPTOY-UHFFFAOYSA-N tert-butyl 4-[2-[7-[1-(4-fluorophenyl)-3-oxopropan-2-yl]sulfanylcarbonyl-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidin-1-yl]acetyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C(=O)CN(C=CN1C2=O)C1=NC(C(=O)SC(CC=1C=CC(F)=CC=1)C=O)=C2OCC1=CC=CC=C1 FRAIEGKCMCPTOY-UHFFFAOYSA-N 0.000 description 1
- RVJRABVHLHJZJI-UHFFFAOYSA-N tert-butyl 4-[2-[7-[5-[(4-fluorophenyl)methyl]-1,3-thiazol-2-yl]-5-oxo-6-phenylmethoxyimidazo[1,2-a]pyrimidin-1-yl]acetyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C(=O)CN(C=CN1C2=O)C1=NC(C=1SC(CC=3C=CC(F)=CC=3)=CN=1)=C2OCC1=CC=CC=C1 RVJRABVHLHJZJI-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000003554 tetrahydropyrrolyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000000034 thioazolyl group Chemical group 0.000 description 1
- 125000005505 thiomorpholino group Chemical group 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Substances C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008903406 | 2008-07-02 | ||
| AU2008903406A AU2008903406A0 (en) | 2008-07-02 | Imidazopyrimidinones and uses thereof | |
| US16193109P | 2009-03-20 | 2009-03-20 | |
| US61/161,931 | 2009-03-20 | ||
| PCT/AU2009/000857 WO2010000031A1 (en) | 2008-07-02 | 2009-07-02 | Imidazopyrimidinones and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2729656A1 true CA2729656A1 (en) | 2010-01-07 |
Family
ID=41465416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2729656A Abandoned CA2729656A1 (en) | 2008-07-02 | 2009-07-02 | Imidazopyrimidinones and uses thereof |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8431581B2 (enExample) |
| EP (1) | EP2291377B1 (enExample) |
| JP (1) | JP5592360B2 (enExample) |
| CA (1) | CA2729656A1 (enExample) |
| WO (1) | WO2010000031A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2729649A1 (en) * | 2008-07-02 | 2010-01-07 | Avexa Limited | Thiazopyrimidinones and uses thereof |
| PL2212324T3 (pl) | 2008-07-02 | 2014-11-28 | Avexa Ltd | Związki posiadające właściwości przeciwwirusowe |
| AR080314A1 (es) | 2010-02-26 | 2012-03-28 | Japan Tobacco Inc | Derivado de 1,3,4,8-tetrahidro-2h-pirido (1,2-a) pirazina y su uso como inhibidor de la hiv integrasa |
| US11042897B2 (en) | 2010-08-30 | 2021-06-22 | Adap.Tv, Inc. | System and method for determining effects of multi-channel media sources on multi-channel conversion events |
| US20160002247A1 (en) * | 2013-03-01 | 2016-01-07 | The University Of Tokyo | 8-substituted imidazopyrimidinone derivative having autotaxin inhibitory activity |
| BR112015028173A2 (pt) | 2013-05-10 | 2017-07-25 | Nimbus Apollo Inc | inibidores de acc e usos dos mesmos |
| EP2994138A4 (en) * | 2013-05-10 | 2016-12-28 | Nimbus Apollo Inc | ACC-HEMMER AND USES THEREOF |
| EP2994139B1 (en) | 2013-05-10 | 2019-04-10 | Gilead Apollo, LLC | Acc inhibitors and uses thereof |
| JP6417403B2 (ja) | 2013-05-10 | 2018-11-07 | ギリアド アポロ, エルエルシー | Acc阻害剤及びその使用 |
| WO2015064714A1 (ja) * | 2013-10-31 | 2015-05-07 | 国立大学法人東京大学 | オートタキシン阻害活性を有する1-置換イミダゾピリミジノン誘導体 |
| MX2022006700A (es) | 2019-12-02 | 2022-09-02 | Storm Therapeutics Ltd | Compuestos poliheterociclicos como inhibidores de mettl3. |
| CN116199605A (zh) * | 2023-02-27 | 2023-06-02 | 上海睿腾医药科技有限公司 | 一种5-氯-2-羟基-二甲基苯磺酰胺的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE15187654T1 (de) | 2001-08-10 | 2016-12-01 | Shionogi & Co., Ltd | Antivirales Mittel |
| US7273859B2 (en) * | 2004-05-12 | 2007-09-25 | Bristol-Myers Squibb Company | HIV integrase inhibitors: cyclic pyrimidinone compounds |
| EP1866313A1 (en) * | 2005-03-31 | 2007-12-19 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Hiv integrase inhibitors |
| KR20100049698A (ko) * | 2006-12-22 | 2010-05-12 | 아벡사 리미티드 | 바이사이클 피리미디논 및 그 용도 |
-
2009
- 2009-07-02 EP EP09771848.0A patent/EP2291377B1/en not_active Not-in-force
- 2009-07-02 US US12/734,042 patent/US8431581B2/en not_active Expired - Fee Related
- 2009-07-02 CA CA2729656A patent/CA2729656A1/en not_active Abandoned
- 2009-07-02 WO PCT/AU2009/000857 patent/WO2010000031A1/en not_active Ceased
- 2009-07-02 JP JP2011515027A patent/JP5592360B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP5592360B2 (ja) | 2014-09-17 |
| US8431581B2 (en) | 2013-04-30 |
| EP2291377A4 (en) | 2011-10-05 |
| JP2011526247A (ja) | 2011-10-06 |
| US20110028487A1 (en) | 2011-02-03 |
| WO2010000031A1 (en) | 2010-01-07 |
| EP2291377A1 (en) | 2011-03-09 |
| EP2291377B1 (en) | 2015-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2729656A1 (en) | Imidazopyrimidinones and uses thereof | |
| JP5535204B2 (ja) | 抗ウイルス特性を有する化合物 | |
| JP5208962B2 (ja) | 二環式ピリミジノンおよびその使用 | |
| EP2247601B1 (en) | Thiazopyrimidinones and uses thereof | |
| JP2022511819A (ja) | ヘテロアリールジヒドロピリミジン誘導体及びb型肝炎感染症を治療する方法 | |
| CN103080113A (zh) | 7,9-氮基-4-氧代-4h-吡啶并[l,2-a]嘧啶-2-羧酸苄基酰胺抗病毒剂 | |
| ES2358550T3 (es) | Pirimidinonas bicíclicas y sus usos. | |
| HK1131615B (en) | Bicyclic pyrimidinones and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140626 |
|
| FZDE | Dead |
Effective date: 20160704 |